New year, new hire: Moderna taps Merck veteran as latest commercial exec
Moderna has plucked a new commercial executive from the ranks at Merck as CEO Stéphane Bancel promises the company is in a “much better place” for 2023 Covid-19 vaccine deliveries.
Chantal Friebertshäuser is joining Moderna on Jan. 1 as senior vice president of commercial, where she’ll be responsible for efforts in Europe, the Middle East and Canada. Chief commercial officer Arpa Garay — who also spent years at Merck — touted a slate of vaccine contracts lined up for 2023 on Moderna’s recent Q3 call, including in Switzerland, Kuwait and Canada, with more to come.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.